Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/25/2012USRE43878 Amidophenoxyindazoles useful as inhibitors of c-Met
12/25/2012US8338648 Topical compositions and methods for epithelial-related conditions
12/25/2012US8338642 Ferric organic compounds, uses thereof and methods of making same
12/25/2012US8338641 Method for treating atypical facial pain
12/25/2012US8338624 Isoflavone derivatives and uses thereof
12/25/2012US8338623 Compounds as cannabinoid receptor ligands
12/25/2012US8338622 Heterocyclic compound
12/25/2012US8338616 Thiazoliums and their use for treating protein aging associated diseases
12/25/2012US8338615 Human protein tyrosine phosphatase inhibitors and methods of use
12/25/2012US8338614 e.g. 2-[5-(5-methyl-1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl]-1-phenylpropan-2-amine; neurodegenerative diseases; preventing the formation of insoluble amyloid beta and arresting the production of amyloid beta
12/25/2012US8338611 Opioid receptor antagonists
12/25/2012US8338608 Inhibitors of ion channels
12/25/2012US8338606 Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
12/25/2012US8338604 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
12/25/2012US8338602 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
12/25/2012US8338599 Compounds having a potentiating effect on the activity of ethionamide and uses thereof
12/25/2012US8338597 Pyridones useful as inhibitors of kinases
12/25/2012US8338595 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12/25/2012US8338594 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
12/25/2012US8338593 Agonists; Treatment of Hepatitis C virus; phosphinate-substituted purine derivatives
12/25/2012US8338592 Fused thiazole derivatives as kinase inhibitors
12/25/2012US8338586 Process of making cladribine
12/25/2012US8338584 Nucleic acid complex and nucleic acid delivery composition
12/25/2012US8338583 Snornai-small nucleolar RNA degradation by RNA interference in trypanosomatids
12/25/2012US8338564 Method for the preparation of phytosterols from tall oil pitch
12/25/2012US8338545 Multi-arm block copolymers as drug delivery vehicles
12/25/2012US8338490 Composition for repelling and deterring vermin
12/25/2012US8338489 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
12/25/2012US8338488 Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants
12/25/2012US8338487 Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulators
12/25/2012US8338486 Methods for the treatment of CNS-related conditions
12/25/2012US8338485 Compositions for the treatment of CNS-related conditions
12/25/2012US8338483 Method for producing acylglycinates
12/25/2012US8338482 Modulating notch1 signaling pathway for treating neuroendocrine tumors
12/25/2012US8338481 Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer
12/25/2012US8338480 Combination treatment of metabolic disorders
12/25/2012US8338479 Enhanced bimatoprost ophthalmic solution
12/25/2012US8338478 Derivatives of 3,3-diphenylpropylamines
12/25/2012US8338477 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
12/25/2012US8338476 Compositions and methods of sensitizing methicillin resistant Staphylococcus aureus to beta-lactam antibiotics
12/25/2012US8338475 Anti-proliferative pharmaceutical composition
12/25/2012US8338474 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
12/25/2012US8338473 Derivatives of psammaplin A, a method for their synthesis and their uses for the prevention or treatment of cancer
12/25/2012US8338472 Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
12/25/2012US8338471 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
12/25/2012US8338470 Dexmedetomidine premix formulation
12/25/2012US8338469 Compounds and compositions as channel activating protease inhibitors
12/25/2012US8338468 Microbicidal composition
12/25/2012US8338467 Compounds as cannabinoid receptor ligands
12/25/2012US8338465 Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
12/25/2012US8338464 Small molecule inhibitors of BCL6
12/25/2012US8338462 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
12/25/2012US8338461 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
12/25/2012US8338460 2-pyridinecarboxamide derivative having GK-activating effect
12/25/2012US8338459 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/25/2012US8338458 Method of treatment using fused aromatic compounds having anti-diabetic activity
12/25/2012US8338457 Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist
12/25/2012US8338456 Cut-point in PTEN protein expression that accurately identifies tumors and is predictive of drug response to a pan-ErbB inhibitor
12/25/2012US8338455 Pyridines or pyrimidines having 4-(hydrogenated 1-pyridyl- or hydrogenated 1-isoquinolyl rings, e.g., N-(4-chlorophenyl)-2-(pyridin-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
12/25/2012US8338454 Nitrile derivatives and their pharmaceutical use and compositions
12/25/2012US8338453 Treatment of progressive neurodegenerative disease with ibudilast
12/25/2012US8338452 Raf inhibitor compounds and methods of use thereof
12/25/2012US8338451 Polysubstituted derivatives of 2-heteroaryl-6-phenylimidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
12/25/2012US8338450 Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
12/25/2012US8338449 Isoquinolinone potassium channel inhibitors
12/25/2012US8338448 Chemokine receptor modulators
12/25/2012US8338447 Pyrido[3,4-B]indoles and methods of use
12/25/2012US8338446 Peripheral opioid receptor antagonists and uses thereof
12/25/2012US8338445 Crystal form of cabergoline
12/25/2012US8338444 Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
12/25/2012US8338443 Chemical compounds
12/25/2012US8338442 Remedies for psychoneurosis
12/25/2012US8338441 Inhibitors of human immunodeficiency virus replication
12/25/2012US8338440 Inhibitors of IAP
12/25/2012US8338439 2,4-disubstituted pyrimidines useful as kinase inhibitors
12/25/2012US8338438 Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
12/25/2012US8338437 Amines as small molecule inhibitors
12/25/2012US8338436 Amorphous form of N-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
12/25/2012US8338435 Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
12/25/2012US8338434 Inhibitors of Akt activity
12/25/2012US8338433 Tyrosine kinase inhibitors as anti-kinetoplastid agents
12/25/2012US8338432 Derivatives of 6,7-dihydro-3H-oxazolo[3,4-a]pyrazine-5,9-dione as PDE-5 inhibitors
12/25/2012US8338431 Phosphodiesterase inhibitors
12/25/2012US8338430 N-substituted piperazines
12/25/2012US8338429 2-acylaminothiazole derivative or salt thereof
12/25/2012US8338428 Methods for administering aripiprazole
12/25/2012US8338427 Methods for administering aripiprazole
12/25/2012US8338426 Piperazinyl derivatives useful as modulators of the neuropeptide Y2 receptor
12/25/2012US8338425 Heterocyclic kinase inhibitors
12/25/2012US8338424 Guanidine-containing compounds useful as muscarinic receptor antagonists
12/25/2012US8338423 Compositions for the treatment of hyperphenylalaninemia
12/25/2012US8338422 Indolin-2-ones and aza-indolin-2-ones
12/25/2012US8338421 Compositions and methods for reversing rebound hyperemia
12/25/2012US8338420 Treatment of Parkinson's disease and enhancement of dopamine signal using PDE 10 inhibitor
12/25/2012US8338418 Dual-acting antihypertensive agents
12/25/2012US8338417 Compounds and compositions as c-kit and PDGFR kinase inhibitors
12/25/2012US8338416 Indole derivatives as inhibitors of histone deacetylase
12/25/2012US8338415 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
12/25/2012US8338414 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/25/2012US8338413 Oxazine derivatives and their use in the treatment of neurological disorders
1 ... 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 ... 7860